Victor Nitti, MD - Medicare Urology in Los Angeles, CA

Victor Nitti, MD is a medicare enrolled "Urology" physician in Los Angeles, California. He graduated from medical school in 1985 and has 39 years of diverse experience with area of expertise as Urology. He is a member of the group practice The Regents Of The University Of California and his current practice location is 200 Ucla Medical Plz Ste 140, Los Angeles, California. You can reach out to his office (for appointments etc.) via phone at (310) 794-7700.

Victor Nitti is licensed to practice in California (license number G70937) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1003800806.

Contact Information

Victor Nitti, MD
200 Ucla Medical Plz Ste 140,
Los Angeles, CA 90095-8344
(310) 794-7700
(310) 794-0211



Physician's Profile

Full NameVictor Nitti
GenderMale
SpecialityUrology
Experience39 Years
Location200 Ucla Medical Plz Ste 140, Los Angeles, California
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Victor Nitti graduated from medical school in 1985
  NPI Data:
  • NPI Number: 1003800806
  • Provider Enumeration Date: 09/07/2005
  • Last Update Date: 11/17/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 8224019724
  • Enrollment ID: I20181018003172

Medical Identifiers

Medical identifiers for Victor Nitti such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003800806NPI-NPPES
01420662MedicaidNY

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2088F0040XUrology - Female Pelvic Medicine And Reconstructive Surgery G70937 (California)Secondary
208800000XUrology G70937 (California)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Ronald Reagan Ucla Medical CenterLos angeles, CAHospital
Santa Monica - Ucla Med Ctr & Orthopaedic HospitalSanta monica, CAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
The Regents Of The University Of California367854543142

News Archive

Newly discovered molecules show potential to treat obesity and fatty liver disease

Amiram Goldblum and his team at the Hebrew University of Jerusalem's Institute for Drug Research have discovered 27 new molecules. These molecules all activate a special protein called PPAR-delta and have the potential to treat fatty liver disease, obesity, diabetic nephrotoxicity, and to heal wounds.

MIT engineers discover way to grow liver-like cells to test potential malaria drugs

In 2008, the World Health Organization announced a global effort to eradicate malaria, which kills about 800,000 people every year. As part of that goal, scientists are trying to develop new drugs that target the malaria parasite during the stage when it infects the human liver, which is crucial because some strains of malaria can lie dormant in the liver for several years before flaring up.

Call for greater caution in prescribing inhaled corticosteroids to COPD sufferers

Lung disease experts at Johns Hopkins are calling for physicians to show much greater caution in prescribing inhaled corticosteroid drugs for people with chronic obstructive pulmonary disease after finding evidence that the widely used anti-inflammatory medications increase the risk of pneumonia by a full third.

Anosmia and changes in brain MRI in COVID-19

Even as the COVID-19 pandemic was sweeping across the world, new symptoms and clinical presentations appeared, often confusing the picture. A case report from Italy, published in the journal JAMA Neurology in May 2020, shows that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be a neurotropic virus, and may cause infection to present primarily with anosmia.

Actavis gets favorable ruling in patent suit against generic Lialda

Actavis plc today confirmed that the United States Court of Appeals for the Federal Circuit has reversed a lower court ruling that Actavis' generic version of Shire's Lialda (mesalamine extended-release tablets) infringes United States Patent No. 6,773,720 (the '720 Patent).

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Victor Nitti allows following entities to bill medicare on his behalf.
Entity NameThe Regents Of The University Of California
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1073582888
PECOS PAC ID: 0143124289
Enrollment ID: O20031120001009

News Archive

Newly discovered molecules show potential to treat obesity and fatty liver disease

Amiram Goldblum and his team at the Hebrew University of Jerusalem's Institute for Drug Research have discovered 27 new molecules. These molecules all activate a special protein called PPAR-delta and have the potential to treat fatty liver disease, obesity, diabetic nephrotoxicity, and to heal wounds.

MIT engineers discover way to grow liver-like cells to test potential malaria drugs

In 2008, the World Health Organization announced a global effort to eradicate malaria, which kills about 800,000 people every year. As part of that goal, scientists are trying to develop new drugs that target the malaria parasite during the stage when it infects the human liver, which is crucial because some strains of malaria can lie dormant in the liver for several years before flaring up.

Call for greater caution in prescribing inhaled corticosteroids to COPD sufferers

Lung disease experts at Johns Hopkins are calling for physicians to show much greater caution in prescribing inhaled corticosteroid drugs for people with chronic obstructive pulmonary disease after finding evidence that the widely used anti-inflammatory medications increase the risk of pneumonia by a full third.

Anosmia and changes in brain MRI in COVID-19

Even as the COVID-19 pandemic was sweeping across the world, new symptoms and clinical presentations appeared, often confusing the picture. A case report from Italy, published in the journal JAMA Neurology in May 2020, shows that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be a neurotropic virus, and may cause infection to present primarily with anosmia.

Actavis gets favorable ruling in patent suit against generic Lialda

Actavis plc today confirmed that the United States Court of Appeals for the Federal Circuit has reversed a lower court ruling that Actavis' generic version of Shire's Lialda (mesalamine extended-release tablets) infringes United States Patent No. 6,773,720 (the '720 Patent).

Read more Medical News

› Verified 1 days ago

Entity NameThe Regents Of The University Of California
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1154389799
PECOS PAC ID: 3678545431
Enrollment ID: O20040811000949

News Archive

Newly discovered molecules show potential to treat obesity and fatty liver disease

Amiram Goldblum and his team at the Hebrew University of Jerusalem's Institute for Drug Research have discovered 27 new molecules. These molecules all activate a special protein called PPAR-delta and have the potential to treat fatty liver disease, obesity, diabetic nephrotoxicity, and to heal wounds.

MIT engineers discover way to grow liver-like cells to test potential malaria drugs

In 2008, the World Health Organization announced a global effort to eradicate malaria, which kills about 800,000 people every year. As part of that goal, scientists are trying to develop new drugs that target the malaria parasite during the stage when it infects the human liver, which is crucial because some strains of malaria can lie dormant in the liver for several years before flaring up.

Call for greater caution in prescribing inhaled corticosteroids to COPD sufferers

Lung disease experts at Johns Hopkins are calling for physicians to show much greater caution in prescribing inhaled corticosteroid drugs for people with chronic obstructive pulmonary disease after finding evidence that the widely used anti-inflammatory medications increase the risk of pneumonia by a full third.

Anosmia and changes in brain MRI in COVID-19

Even as the COVID-19 pandemic was sweeping across the world, new symptoms and clinical presentations appeared, often confusing the picture. A case report from Italy, published in the journal JAMA Neurology in May 2020, shows that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be a neurotropic virus, and may cause infection to present primarily with anosmia.

Actavis gets favorable ruling in patent suit against generic Lialda

Actavis plc today confirmed that the United States Court of Appeals for the Federal Circuit has reversed a lower court ruling that Actavis' generic version of Shire's Lialda (mesalamine extended-release tablets) infringes United States Patent No. 6,773,720 (the '720 Patent).

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Victor Nitti is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Victor Nitti, MD
5767 W Century Blvd Ste 400,
Los Angeles, CA 90045-5631

Ph: () -
Victor Nitti, MD
200 Ucla Medical Plz Ste 140,
Los Angeles, CA 90095-8344

Ph: (310) 794-7700

News Archive

Newly discovered molecules show potential to treat obesity and fatty liver disease

Amiram Goldblum and his team at the Hebrew University of Jerusalem's Institute for Drug Research have discovered 27 new molecules. These molecules all activate a special protein called PPAR-delta and have the potential to treat fatty liver disease, obesity, diabetic nephrotoxicity, and to heal wounds.

MIT engineers discover way to grow liver-like cells to test potential malaria drugs

In 2008, the World Health Organization announced a global effort to eradicate malaria, which kills about 800,000 people every year. As part of that goal, scientists are trying to develop new drugs that target the malaria parasite during the stage when it infects the human liver, which is crucial because some strains of malaria can lie dormant in the liver for several years before flaring up.

Call for greater caution in prescribing inhaled corticosteroids to COPD sufferers

Lung disease experts at Johns Hopkins are calling for physicians to show much greater caution in prescribing inhaled corticosteroid drugs for people with chronic obstructive pulmonary disease after finding evidence that the widely used anti-inflammatory medications increase the risk of pneumonia by a full third.

Anosmia and changes in brain MRI in COVID-19

Even as the COVID-19 pandemic was sweeping across the world, new symptoms and clinical presentations appeared, often confusing the picture. A case report from Italy, published in the journal JAMA Neurology in May 2020, shows that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be a neurotropic virus, and may cause infection to present primarily with anosmia.

Actavis gets favorable ruling in patent suit against generic Lialda

Actavis plc today confirmed that the United States Court of Appeals for the Federal Circuit has reversed a lower court ruling that Actavis' generic version of Shire's Lialda (mesalamine extended-release tablets) infringes United States Patent No. 6,773,720 (the '720 Patent).

Read more News

› Verified 1 days ago


Urology Doctors in Los Angeles, CA

Dr. Saum Bobak Ghodoussipour, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 1516 San Pablo St Fl 5, Los Angeles, CA 90033
Phone: 323-865-3700    
Dr. Carol Joan Bennett, M.D.
Urology
Medicare: Medicare Enrolled
Practice Location: 11301 Wilshire Blvd # 10h2, Los Angeles, CA 90073
Phone: 310-478-3711    Fax: 310-268-4967
Arie Belldegrun, MD
Urology
Medicare: Medicare Enrolled
Practice Location: 200 Medical Plz, Suite 140, Los Angeles, CA 90095
Phone: 310-794-7700    Fax: 310-301-8751
Dr. Stuart Holden,
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 200 Ucla Medical Plz Ste 140, Los Angeles, CA 90095
Phone: 310-825-1172    Fax: 310-794-0987
Jay J Stein, M.D.
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 8635 W 3rd St, Suite 460w, Los Angeles, CA 90048
Phone: 310-652-8810    Fax: 310-652-0334
Dr. Philip Werthman, MD
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 2080 Century Park E Ste 907, Los Angeles, CA 90067
Phone: 310-277-2873    Fax: 310-286-2139

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.